Although NRAS mutations have been reported in 14% of human melanoma cell lines and 15–25% of melanoma clinical specimens [15–17], nevertheless, HRAS and KRAS mutations are not common in melanoma [12]. This evidence concerns the gene KRAS and melanoma.